In recent years, Dongfang Pharmaceutical Company, a subsidiary of Oriental Group, has produced a number of new drugs with remarkable efficacy, such as drugs for the treatment of cardiovascular diseases and inhibition of cancer cells, which are very well-known in China, which has greatly alleviated the impact of pharmaceutical companies from advanced countries in the world on China. The initials of the new domain name Kele Novel Network (k1xsw), the largest free romance Chinese website, hurry up. Bayi Novel Network ww Network W. Text 81zw.com

However, after all, the Huaxia pharmaceutical industry has just been developed in recent years, and there is still a certain gap with the world's top countries, especially in the research and development investment of drugs, the gap is even greater, so in fact, Oriental Pharmaceutical is one of the best in China, but it cannot compete with the world's top pharmaceutical companies.

What is even more unacceptable to Huaxia pharmaceutical people is that none of the top 50 pharmaceutical companies in the world belong to Huaxia.

You must know that even countries like Asan have pharmaceutical companies in the top 50, and country R has nearly ten companies in this ranking, not to mention countries like the United States, which almost occupy the vast majority of the top seats.

Medicine is the foundation of a country's health and the urgent needs of the people, and Oriental Group has invested a huge amount of research funds every year in recent years, hoping to build Oriental Pharmaceutical Company into a world-class pharmaceutical company.

However, the pharmaceutical industry is a special industry, and each new drug requires a lot of money and a long time and cycle from research and development to trial and then to approval and formal production.

Huaxia has been too flashy in recent years, companies want to make quick money, few companies can invest huge amounts of research and real innovation, and many so-called new drugs are probably to change some unimportant ingredients and reapply for a new drug name, which is a new drug. 81 Chinese ww a w. say 81 8z eight w say .1 c net o a m

The price of new drugs immediately went up, and the company made money, but the people were depressed, why are new drugs so expensive, but the effect is not as good as the previous few cents. Romance debuts

Of course, there are still a large number of pharmaceutical people in China who want to truly develop the Chinese pharmaceutical industry, and Dongfang Pharmaceutical is one of the representatives.

However, there are too few outstanding talents in domestic medicine, and Oriental Pharmaceutical has also reached the bottleneck of the exhibition in the past two years. For example, the company has not yet developed a new cardiovascular drug that convinces the world.

As one of the core industries that Oriental Group attaches the most importance to, Oriental Pharmaceutical, the president, has a very high degree of attention.

In the past few days, she will go to Dongfang Pharmaceutical Company from time to time to investigate, especially the new drug research room of Dongfang Pharmaceutical. It's the place she goes to the most.

However, after her investigation, there was an astonishing inside story, the huge amount of research funds invested by the Eastern Group in recent years was swallowed up with various so-called new drugs, as for these so-called new drugs, they are some problem drugs that cannot be put into production. Some are even generic drugs and infringing drugs, and if Dongfang Pharmaceutical really produces these drugs, then Dongfang Pharmaceutical will not be far from going out of business, and compensation alone will bankrupt the company.

Dongfang Mengyun has always been a vigorous and resolute character, and soon the company's big moth was dug out, and Lou Xinmin, director of the research department, had the biggest problem, if it weren't for the impact and the impact on the group's stocks, Dongfang Mengyun would definitely send this guy to the class, he had embezzled tens of millions of research fees in just three years. Bayi Chinese w small w said w one. Net 81zw.com

Of course. Lou Xinmin's problem is not an isolated case, in fact, most of the people in the entire research team have some problems, and the key to this problem is the malfeasance of Yan Zòng, the general manager of Dongfang Pharmaceutical.

Oriental Mengyun turned out the personnel files of the past research team and left collectively, and now the original research director Jing Caiqian is a really capable and hard-working person, and the products that Dongfang Pharmaceutical has sold well in recent years have also been developed when he was in office.

How could such a talented person leave? When Dongfang Mengyun carefully flipped through the files, he saw that there seemed to be some problems here, Jing Caiqian was dismissed because of the style of men and women, and the language on the file was unknown, and there was an unknown inside story at a glance.

"It's hard to start a business. It is even more difficult to keep the business, and the Oriental Group seems to be glamorous on the surface, but in fact, it is full of holes, and one is not careful. It will collapse like the building Chu Hui Huafeng building in Ning City. I will definitely not let this scene live, no matter who it is, as long as it is a moth in the company, it must be dug up and severely punished. ”

For the company such a grim status of affairs. Dongfang Mengyun couldn't help but sigh in her heart, but since her father handed over the business to her, she must let her rejuvenate.

However, the problems formed by pharmaceutical companies for many years are intricate and intertwined, and Dongfang Mengyun is also quite a headache to deal with, and on Friday, she originally wanted to go to Jinxian County to accompany Yunduo after work, but it seems that she is going to break her promise.

The research team was almost wiped out, and most of these people could no longer be used, but Dongfang Mengyun was worried, where would they find good researchers for a while?

In particular, the director of the research department must not only have the ability to prescribe new drugs, but also have the ability to manage the team, and also need to have a certain age precipitation and prestige, which is really difficult to find.

Fortunately, Oriental Group has cooperated with many large talent agencies and headhunting companies at home and abroad, and Oriental Mengyun believes that as long as you cast a wide net and are willing to spend money, talents can still be found, and it is only a matter of time.

For Dongfang Pharmaceutical, the time is too urgent, and after dealing with the current research team, the research department must be replaced, where can this person go to find it in a short time? Dongfang Mengyun was also a little worried.

Suddenly, a piece of news fed back by the secretary aroused Dongfang Mengyun's great interest.

"On July 24, Dr. Jing Caiqian, who once served as the research team leader of Ruifeng Pharmaceutical Company, a well-known pharmaceutical company in country R, returned to China with his new research on cardiovascular topics and a huge amount of venture capital funds, and is seeking domestic companies interested in pharmaceutical industry to cooperate in research and production." The back is a relevant resume and introduction about Dr. Jing Caiqian.

Looking at his academic qualifications and work experience, Dongfang Mengyun is now a very well-known person in the pharmaceutical industry, and many world-class pharmaceutical companies have thrown olive branches to him.

However, Jing Caiqian is a patriot, and he wants to use this new drug to put Huaxia Pharmaceutical on the international stage, so he rejected foreign companies and prepared to return to China to start a business.

"Jing Caiqian, isn't he the original research director of Dongfang Pharmaceutical? Sure enough, people with the ability will shine wherever they go, but he was dismissed by Oriental Pharmaceutical back then, and now he will still accept the cooperation of Oriental Pharmaceutical? ”

Thinking of this, Dongfang Mengyun's jade face couldn't help but have a trace of gloom, but then it dissipated, she smiled faintly, this is a challenge and an opportunity, such a talent must be used by the Oriental Group again.

However, what Dongfang Mengyun didn't know was that as soon as the news of Jing Caiqian's return to China was reported by the media, major domestic pharmaceutical companies came to the door one after another to seek cooperation, including Wulin Ximen Pharmaceutical under the jurisdiction of Ximen Bingbing.

The strong in the dark world are respected, and they speak with strength.

Urban workplaces are judged by business talent.

In comparison, the dark world is simpler, and you only need to look at your personal strength, but in the urban workplace, you can see more things and it is more difficult to control.

Similar to the difficulties encountered by Dongfang Mengyun, in fact, Ximen Bingbing has been very troubled recently, the general manager of the Wulin Branch of Ximen Group is not easy to be, many people respect her on the surface, but in fact she is yang and yin, and some people even say that she is a vase behind her back, which makes her very angry, but the city has the rules of the city, and she doesn't want to bring the dark world to the city, so she needs to make achievements to stand firm and give those who look down on her a beautiful riposte, At present, the cooperation between Ximen Pharmaceutical and Dr. Jing Caiqian is an opportunity. (To be continued.) )

PS: Bow and thank you for the monthly pass and recommended ticket support of the "Four Spaces".